Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug.
Tundo GR, Sbardella D, Oddone F, Grasso G, Marini S, Atzori MG, Santoro AM, Milardi D, Bellia F, Macari G, Graziani G, Polticelli F, Cascio P, Parravano M, Coletta M.
Tundo GR, et al. Among authors: polticelli f.
Biomolecules. 2022 Feb 16;12(2):315. doi: 10.3390/biom12020315.
Biomolecules. 2022.
PMID: 35204815
Free PMC article.